A new Wiley study explores the potential of static stretching to improve blood glucose control and vascular health in adults with type 1 diabetes, offering a simple, accessible addition to traditional exercise regimes.
A new Wiley study is examining whether static stretching could become a practical adjunct to usual exercise advice for adults living with type 1 diabetes, a condition that usually requires lifelong insulin treatment and close blood glucose monitoring, according to Johns Hopkins Medicine, MedlinePlus and the Merck Manual. The paper frames the work around a familiar problem in diabetes care: although physical activity can improve glucose control and reduce cardiometabolic risk, many people with type 1 diabetes struggle to maintain regular exercise because of fear of hypoglycaemia, the need to adjust insulin, and the complexity of balancing food intake and monitoring.
The study focuses on type 1 diabetes as an autoimmune disease in which the body destroys insulin-producing beta cells, leaving patients dependent on external insulin. That distinction matters because exercise can affect glucose in different ways depending on intensity and duration. The research summary notes that moderate aerobic work can sometimes lower blood sugar too far if insulin and carbohydrate intake are not adapted, while harder anaerobic activity may push glucose up. Resistance training, by contrast, has been linked in earlier evidence to better insulin sensitivity, lower insulin needs and reductions in long-term glucose markers such as HbA1c.
Against that backdrop, the authors argue that stretching deserves more attention than it usually receives. Static stretching can be done with little equipment, in a small space and without a gym, making it attractive for people who find more structured exercise difficult to sustain. The paper also points to emerging evidence that stretching may have effects beyond flexibility, including possible benefits for arterial stiffness, a concern in type 1 diabetes because vascular changes can worsen as the disease progresses.
The trial itself is designed as a feasibility study rather than a definitive test of clinical benefit. Its main purpose is to see whether a six-week whole-body stretching programme can be delivered safely and whether participants will attend, adhere and remain in the study. The researchers are also looking for early signals on glucose responses, insulin requirements and insulin sensitivity, with the aim of shaping a larger future trial. If those results are encouraging, stretching could emerge as a low-cost, low-impact option to complement, not replace, aerobic and resistance exercise in type 1 diabetes care.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
